Virtual Pulmonary Rehabilitation Program for COPD Patients; a Pilot Study

NCT06915740 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-04-08

No results posted yet for this study

Summary

The goal of this pilot study is to investigate the feasibility of a virtual rehabilitation program in COPD patients. The main questions it aims to answer are:

1. To facilitate a safe rollout of the remote rehabilitation program for COPD patients in Southwest Finland.
2. To identify and subsequently improve limitations of the rehabilitation program.
3. To evaluate the levels of participant engagement and adherence to the digital COPD rehabilitation program over an extended period to understand its sustainability and long-term impact.
4. To determine the effectiveness of the digital COPD rehabilitation program in improving lung function, exercise capacity, and quality of life among participants
5. To assess the impact of the digital program on healthcare resource utilization, including hospital readmissions, emergency room visits, and outpatient visits related to COPD management.
6. To measure participant satisfaction, usability, and overall experience with the digital platform to identify areas for improvement and enhance user engagement.
7. To evaluate the cost-effectiveness of implementing the digital program compared to conventional rehabilitation methods, considering direct healthcare costs.

Participants will be enrolled in a virtual rehabilitation program, and a proportion of the patients is invited for focus group discussion to assess their experiences.

Conditions

  • COPD (Chronic Obstructive Pulmonary Disease)

Interventions

OTHER

Exercise

virtual rehabilitation, including endurance exercise, strength training, breathing exercises, patient education, dietary advice

Sponsors & Collaborators

  • Turku University Hospital

    lead OTHER_GOV

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-31
Primary Completion
2026-06-30
Completion
2026-06-30

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06915740 on ClinicalTrials.gov